AI assistant
BIO-TECHNE Corp — Director's Dealing 2024
Aug 19, 2024
30718_dirs_2024-08-19_af1f63b9-b7b0-4fd0-b2de-ec683968d821.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-08-15
Reporting Person: Bohnen Shane (SVP - General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-15 | Common Stock | M | 49 | — | Acquired | 1696 | Direct |
| 2024-08-15 | Common Stock | F | 15 | $74.91 | Disposed | 1681 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | Restricted Stock Units | $ | M | 49 | Disposed | Common Stock (49) | Direct | |
| 2024-08-15 | Performance Restricted Stock Units | $ | A | 10012 | Acquired | Common Stock (10012) | Direct | |
| 2024-08-15 | Restricted Stock Units | $ | A | 5006 | Acquired | Common Stock (5006) | Direct | |
| 2024-08-15 | Stock Option (Right to Buy) | $74.91 | A | 13488 | Acquired | 2034-08-15 | Common Stock (13488) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (8848) | 8848 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (8944) | 8944 | Direct |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (3460) | 3460 | Direct |
| Stock Option (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (3508) | 3508 | Direct |
| Stock Option (Right to Buy) | $73.76 | 2030-04-03 | Common Stock (3928) | 3928 | Direct |
| Restricted Stock Units | $ | Common Stock (4519) | 4519 | Direct | |
| Stock Option (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (16302) | 16302 | Direct |
| Performance Restricted Stock Units | $ | Common Stock (4802) | 4802 | Direct | |
| Performance Stock Option (Right to Buy) | $84.61 | Common Stock (12924) | 12924 | Direct |
Footnotes
F1: Fully exercisable.
F2: Options to purchase 864 shares vest on each of 8/6/2022, 8/6/2024 and 8/6/2025, and options to purchase 868 shares vest on 8/6/2023.
F3: Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
F4: Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F6: 2,260 restricted stock units vest on 4/3/2025 and 2,259 restricted stock units vest on 4/3/2026.
F7: Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
F8: 49 restricted stock units vest on 8/15/2024 and 8/15/2026, and 50 restricted stock units vest on 8/15/2025
F9: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11: 1,668 restricted stock units vest on 8/15/2025, and 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
F12: Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.